Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Operating Leases (2023 - 2024)

Historic Operating Leases for BioLineRx (BLRX) over the last 2 years, with Q4 2024 value amounting to $1.6 million.

  • BioLineRx's Operating Leases fell 1182.62% to $1.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.6 million, marking a year-over-year decrease of 1182.62%. This contributed to the annual value of $1.6 million for FY2024, which is 1182.62% down from last year.
  • As of Q4 2024, BioLineRx's Operating Leases stood at $1.6 million, which was down 1182.62% from $1.8 million recorded in Q4 2023.
  • BioLineRx's 5-year Operating Leases high stood at $1.8 million for Q4 2023, and its period low was $1.6 million during Q4 2024.